| Analysis | Metabolite Name | Measured Value | Units | Group | Timepoint | Gender | Age at start of study (years) |
|---|---|---|---|---|---|---|---|
| GC POSITIVE ION MODE | palmitoleic acid | 860 | Counts | Placebo | Recovery (days 68-70) | Male castrated | 7 |
| GC POSITIVE ION MODE | palmitoleic acid | 906 | Counts | Synbiotic | Completion of treatment (days 26-28) | Female spayed | 5 |
| GC POSITIVE ION MODE | palmitoleic acid | 995 | Counts | Placebo | Recovery (days 68-70) | Female spayed | 5 |
| GC POSITIVE ION MODE | palmitoleic acid | 1049 | Counts | Synbiotic | Recovery (days 68-70) | Male castrated | 9 |
| GC POSITIVE ION MODE | palmitoleic acid | 1069 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | palmitoleic acid | 1099 | Counts | Synbiotic | Recovery (days 68-70) | Male castrated | 7 |
| GC POSITIVE ION MODE | palmitoleic acid | 1291 | Counts | Placebo | Recovery (days 68-70) | Male castrated | 7 |
| GC POSITIVE ION MODE | palmitoleic acid | 1362 | Counts | Placebo | Recovery (days 68-70) | Female spayed | 7 |
| GC POSITIVE ION MODE | palmitoleic acid | 1415 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 7 |
| GC POSITIVE ION MODE | palmitoleic acid | 1460 | Counts | Synbiotic | Recovery (days 68-70) | Male castrated | 9 |
| GC POSITIVE ION MODE | palmitoleic acid | 1473 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 9 |
| GC POSITIVE ION MODE | palmitoleic acid | 1480 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 5 |
| GC POSITIVE ION MODE | palmitoleic acid | 1515 | Counts | Synbiotic | Recovery (days 68-70) | Female spayed | 5 |
| GC POSITIVE ION MODE | palmitoleic acid | 1518 | Counts | Placebo | Baseline (days 5-7) | Male castrated | 7 |
| GC POSITIVE ION MODE | palmitoleic acid | 1540 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 7 |
| GC POSITIVE ION MODE | palmitoleic acid | 1632 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 9 |
| GC POSITIVE ION MODE | palmitoleic acid | 1700 | Counts | Placebo | Baseline (days 5-7) | Male castrated | 7 |
| GC POSITIVE ION MODE | palmitoleic acid | 1768 | Counts | Synbiotic | Recovery (days 68-70) | Female spayed | 10 |
| GC POSITIVE ION MODE | palmitoleic acid | 1831 | Counts | Placebo | Recovery (days 68-70) | Female spayed | 10 |
| GC POSITIVE ION MODE | palmitoleic acid | 1933 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 5 |
| GC POSITIVE ION MODE | palmitoleic acid | 2276 | Counts | Placebo | Recovery (days 68-70) | Male castrated | 9 |
| GC POSITIVE ION MODE | palmitoleic acid | 2306 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 7 |
| GC POSITIVE ION MODE | palmitoleic acid | 2426 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 10 |
| GC POSITIVE ION MODE | palmitoleic acid | 2482 | Counts | Placebo | Completion of treatment (days 26-28) | Male castrated | 9 |
| GC POSITIVE ION MODE | palmitoleic acid | 2500 | Counts | Placebo | Recovery (days 68-70) | Female spayed | 10 |
| GC POSITIVE ION MODE | palmitoleic acid | 2616 | Counts | Synbiotic | Recovery (days 68-70) | Male castrated | 9 |
| GC POSITIVE ION MODE | palmitoleic acid | 2733 | Counts | Synbiotic | Baseline (days 5-7) | Female spayed | 5 |
| GC POSITIVE ION MODE | palmitoleic acid | 3279 | Counts | Synbiotic | Recovery (days 68-70) | Male castrated | 9 |
| GC POSITIVE ION MODE | palmitoleic acid | 3366 | Counts | Placebo | Completion of treatment (days 26-28) | Male castrated | 7 |
| GC POSITIVE ION MODE | palmitoleic acid | 3419 | Counts | Placebo | Completion of treatment (days 26-28) | Female spayed | 5 |
| GC POSITIVE ION MODE | palmitoleic acid | 3711 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | palmitoleic acid | 4042 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | palmitoleic acid | 4092 | Counts | Placebo | Baseline (days 5-7) | Male castrated | 9 |
| GC POSITIVE ION MODE | palmitoleic acid | 4120 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | palmitoleic acid | 4202 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | palmitoleic acid | 4303 | Counts | Synbiotic | Completion of treatment (days 26-28) | Female spayed | 10 |
| GC POSITIVE ION MODE | palmitoleic acid | 4304 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | palmitoleic acid | 4307 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 9 |
| GC POSITIVE ION MODE | palmitoleic acid | 4321 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | palmitoleic acid | 4388 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | palmitoleic acid | 4516 | Counts | Placebo | Recovery (days 68-70) | Female spayed | 5 |
| GC POSITIVE ION MODE | palmitoleic acid | 4562 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | palmitoleic acid | 4568 | Counts | Placebo | Completion of treatment (days 26-28) | Male castrated | 7 |
| GC POSITIVE ION MODE | palmitoleic acid | 4612 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | palmitoleic acid | 4685 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | palmitoleic acid | 4802 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 9 |
| GC POSITIVE ION MODE | palmitoleic acid | 5111 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 10 |
| GC POSITIVE ION MODE | palmitoleic acid | 5380 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 9 |
| GC POSITIVE ION MODE | palmitoleic acid | 5844 | Counts | Synbiotic | Baseline (days 5-7) | Female spayed | 10 |
| GC POSITIVE ION MODE | palmitoleic acid | 6091 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 9 |
| GC POSITIVE ION MODE | palmitoleic acid | 20158 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 9 |
| GC POSITIVE ION MODE | palmitoleic acid | 25130 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 9 |
| GC POSITIVE ION MODE | palmitoleic acid | 38016 | Counts | Synbiotic | Recovery (days 68-70) | Male castrated | 9 |
| GC POSITIVE ION MODE | palmitoleic acid | 59314 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 9 |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|